Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.

arrhythmogenic cardiomyopathy cardiac magnetic resonance dilated cardiomyopathy genotype late gadolinium enhancement

Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
01 03 2020
Historique:
received: 12 05 2019
revised: 15 06 2019
accepted: 24 06 2019
pubmed: 19 7 2019
medline: 29 6 2021
entrez: 19 7 2019
Statut: ppublish

Résumé

Myocardial scar detected by cardiovascular magnetic resonance has been associated with sudden cardiac death in dilated cardiomyopathy (DCM). Certain genetic causes of DCM may cause a malignant arrhythmogenic phenotype. The concepts of arrhythmogenic left ventricular (LV) cardiomyopathy (ALVC) and arrhythmogenic DCM are currently ill-defined. We hypothesized that a distinctive imaging phenotype defines ALVC. Eighty-nine patients with DCM-associated mutations [desmoplakin (DSP) n = 25, filamin C (FLNC) n = 7, titin n = 30, lamin A/C n = 12, bcl2-associated athanogene 3 n = 3, RNA binding motif protein 20 n = 3, cardiac sodium channel NAv1.5 n = 2, and sarcomeric genes n = 7] were comprehensively phenotyped. Clustering analysis resulted in two groups: 'DSP/FLNC genotypes' and 'non-DSP/FLNC'. There were no significant differences in age, sex, symptoms, baseline electrocardiography, arrhythmia burden, or ventricular volumes between the two groups. Subepicardial LV late gadolinium enhancement with ring-like pattern (at least three contiguous segments in the same short-axis slice) was observed in 78.1% of DSP/FLNC genotypes but was absent in the other DCM genotypes (P < 0.001). Left ventricular ejection fraction (LVEF) and global longitudinal strain were lower in other DCM genotypes (P = 0.053 and P = 0.015, respectively), but LV regional wall motion abnormalities were more common in DSP/FLNC genotypes (P < 0.001). DSP/FLNC patients with non-sustained ventricular tachycardia (NSVT) had more LV scar (P = 0.010), whereas other DCM genotypes patients with NSVT had lower LVEF (P = 0.001) than patients without NSVT. DSP/FLNC genotypes cause more regionality in LV impairment. The most defining characteristic is a subepicardial ring-like scar pattern in DSP/FLNC, which should be considered in future diagnostic criteria for ALVC.

Identifiants

pubmed: 31317183
pii: 5533094
doi: 10.1093/ehjci/jez188
doi:

Substances chimiques

Contrast Media 0
Gadolinium AU0V1LM3JT

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

326-336

Subventions

Organisme : British Heart Foundation
ID : FS/19/35/34374
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T005181/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/20/2/34841
Pays : United Kingdom

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

João B Augusto (JB)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Institute of Cardiovascular Science, University College London, London, UK.

Rocio Eiros (R)

Cardiovascular Imaging Unit, Hospital Universitario La Paz, Madrid, Spain.

Eleni Nakou (E)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.

Sara Moura-Ferreira (S)

Cardiology Department, Hospital do Divino Espírito Santo, Ponta Delgada, Portugal.

Thomas A Treibel (TA)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Institute of Cardiovascular Science, University College London, London, UK.

Gabriella Captur (G)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Institute of Cardiovascular Science, University College London, London, UK.
NIHR University College London Hospitals, Biomedical Research Center, Tottenham Court Road, London, UK.

Mohammed M Akhtar (MM)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Institute of Cardiovascular Science, University College London, London, UK.

Alexandros Protonotarios (A)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.

Thomas D Gossios (TD)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.

Konstantinos Savvatis (K)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Institute of Cardiovascular Science, University College London, London, UK.

Petros Syrris (P)

Institute of Cardiovascular Science, University College London, London, UK.

Saidi Mohiddin (S)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
William Harvey Research Institute, Queen Mary University of London, London, UK.

James C Moon (JC)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Institute of Cardiovascular Science, University College London, London, UK.
NIHR University College London Hospitals, Biomedical Research Center, Tottenham Court Road, London, UK.

Perry M Elliott (PM)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Institute of Cardiovascular Science, University College London, London, UK.

Luis R Lopes (LR)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Institute of Cardiovascular Science, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH